In this episode of the CanadianSME Small Business Podcast, host Maheen Bari sits down with Nick Kadysh, founder and CEO of PharmAla Biotech, to uncover how this pioneering Toronto-based life sciences company is leading the way in MDMA-assisted therapies for mental health.
With a career spanning regulatory leadership roles at JUUL Labs and General Electric Canada, Nick’s journey into biotechnology brings a unique blend of public affairs expertise and innovation to the healthcare space. Through PharmAla’s groundbreaking work, MDMA and MDXX-class molecules are now being manufactured and researched to treat PTSD and support mental health globally.
Responses